SEC Company Response from SIRNA THERAPEUTICS INC (CIK 0000892112) — Dec 22, 2005

SIRNA THERAPEUTICS INC (CIK 0000892112)
Date: Dec. 22, 2005 · CIK: 0000892112 · Accession: 0001144204-05-040760

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-27914

Referenced dates: December 19, 2005

Date

Dec. 22, 2005

Author

Not clearly detected

Form

CORRESP

Company

SIRNA THERAPEUTICS INC (CIK 0000892112)

Letter

VIA EDGAR Securities and Exchange Commission Comment Letter dated December 19, 2005 regarding Form 10-K for the Fiscal Year Ended December 31, 2004 and Form 10-Q for the Quarterly Period Ended September 30, File No. 000-27914

Dear Ms. Akins:

We write to you regarding the above-captioned comment letter (the “Comment Letter”), which indicates that a response is required within 10 business days. As discussed in our phone call with you on December 22, 2005, due to the holiday season, the individuals in our company with the requisite knowledge to respond to the Comment Letter are out of the office, returning on January 3, 2006. Therefore, we respectfully request an extension of the response time to the Comment Letter until January 16, 2006, which will allow us to properly respond to the issues raised in the Comment Letter.

If you require any additional information regarding this request, please contact me at (303) 546-8108 or Gene Levoff at O’Melveny & Myers LLP, our outside counsel, at (650) 473-2674.

Very truly yours,
SIRNA THERAPEUTICS, INC.

Show Raw Text

CORRESP
1
filename1.htm

    Sirna
      Therapeutics, Inc.

    185
      Berry
      Street, Suite 6504

    San
      Francisco, California 94107

    (415)
      512-7624

    December
      22, 2005

    VIA
      EDGAR

    Ms.
      Tabatha Akins

    Staff
      Accountant

    Securities
      and Exchange Commission

    100
      F
      Street, N.E.

    Washington,
      D.C.  20549

              Re:

              Sirna
                Therapeutics,
                Inc.

              Comment
                Letter dated December 19, 2005
                regarding

              Form
                10-K for the Fiscal Year Ended December 31, 2004
                and

              Form
                10-Q for the Quarterly Period Ended September 30,
                2005

              File
                No. 000-27914

    Dear
      Ms.
      Akins:

    We
      write
      to you regarding the above-captioned comment letter (the “Comment Letter”),
      which indicates that a response is required within 10 business days. As
      discussed in our phone call with you on December 22, 2005, due to the holiday
      season, the individuals in our company with the requisite knowledge to respond
      to the Comment Letter are out of the office, returning on January 3, 2006.
      Therefore, we respectfully request an extension of the response time to the
      Comment Letter until January 16, 2006, which will allow us to properly respond
      to the issues raised in the Comment Letter.

    If
      you
      require any additional information regarding this request, please contact me
      at
      (303) 546-8108 or Gene Levoff at O’Melveny & Myers LLP, our outside counsel,
      at (650) 473-2674.

              Very truly yours,

              SIRNA THERAPEUTICS, INC.

            By:
            /s/
              Patti Ketchner

              Patti
                Ketchner

              Vice
                President, Finance and Corporate Controller

                (Acting
                  Principal Financial and Accounting
                  Officer)

SecProbe.io